PH20924A - Intravenously administrable human immunoglobulin and process for itsa preparation - Google Patents
Intravenously administrable human immunoglobulin and process for itsa preparationInfo
- Publication number
- PH20924A PH20924A PH28338A PH28338A PH20924A PH 20924 A PH20924 A PH 20924A PH 28338 A PH28338 A PH 28338A PH 28338 A PH28338 A PH 28338A PH 20924 A PH20924 A PH 20924A
- Authority
- PH
- Philippines
- Prior art keywords
- itsa
- preparation
- human immunoglobulin
- intravenously administrable
- administrable
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH74182 | 1982-02-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH20924A true PH20924A (en) | 1987-06-05 |
Family
ID=4194125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH28338A PH20924A (en) | 1982-02-08 | 1983-01-03 | Intravenously administrable human immunoglobulin and process for itsa preparation |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0085747B2 (en) |
| JP (1) | JPS58159424A (en) |
| AR (1) | AR229486A1 (en) |
| AT (1) | ATE19735T1 (en) |
| AU (1) | AU554817B2 (en) |
| DE (1) | DE3271181D1 (en) |
| DK (1) | DK157367C (en) |
| ES (1) | ES518181A0 (en) |
| FI (1) | FI73597C (en) |
| PH (1) | PH20924A (en) |
| PT (1) | PT75979B (en) |
| ZA (1) | ZA828687B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58180433A (en) * | 1982-04-16 | 1983-10-21 | Fujirebio Inc | Method for removing anti-complement agents from immunoglobulins |
| JPH08787B2 (en) * | 1982-08-30 | 1996-01-10 | バクスター、インターナショナル、インコーポレイテッド | Method for producing composition containing gamma globulin |
| US4439421A (en) * | 1982-08-30 | 1984-03-27 | Baxter Travenol Laboratories, Inc. | Stabilized gamma globulin concentrate |
| JP2691708B2 (en) * | 1984-09-26 | 1997-12-17 | 住友製薬株式会社 | Human monoclonal antibody and method for producing the same |
| GB8519848D0 (en) * | 1985-08-07 | 1985-09-11 | Schweiz Rotes Kreuz | Treatment of chronic inflammatory disease |
| DE3641115A1 (en) * | 1986-12-02 | 1988-06-16 | Lentia Gmbh | METHOD FOR PRODUCING AN INTRAVENOUS APPLICABLE AND STABLE IN LIQUID FORM IMMUNOGLOBULINS |
| AT389817B (en) * | 1987-01-22 | 1990-02-12 | Schwab & Co Ges Mbh | Process for the preparation of an immunoglobulin which is stable in liquid form for intravenous administration |
| DE3863908D1 (en) * | 1987-11-27 | 1991-08-29 | Akzo Nv | STABILIZATION OF ANTIBODY. |
| DE3927111C3 (en) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Process for the preparation of unmodified intravenous IgM and / or IgA-containing immunoglobulin preparations |
| JPH0778025B2 (en) * | 1990-03-20 | 1995-08-23 | 日本赤十字社 | Method for producing immunoglobulin G |
| US5256771A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation |
| EP0659767B2 (en) * | 1993-12-27 | 2002-11-06 | ZLB Bioplasma AG | Process to prepare an anti-D immunoglobulin G concentrate and pharmaceutical compositions comprising it |
| RU2128509C1 (en) * | 1996-07-08 | 1999-04-10 | Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского | Method of preparing human ciq-complement subcomponent |
| RU2178309C2 (en) * | 2000-01-12 | 2002-01-20 | Российский научно-исследовательский институт геронтологии | Antithymocytic globulin for intravenous injection and method for its obtaining |
| TWI320788B (en) | 2005-05-25 | 2010-02-21 | Hoffmann La Roche | Method for the purification of antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2500076C3 (en) * | 1975-01-02 | 1982-11-18 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Process for the production of intravenously tolerated gamma globulins |
| DE2527064C3 (en) * | 1975-06-18 | 1979-11-15 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Process for the production of an intravenous native human immunoglobulin preparation with a natural half-life and unchanged antibody activity compared to the starting material |
| US4126605A (en) * | 1975-12-29 | 1978-11-21 | Plasmesco Ag | Process of improving the compatibility of gamma globulins |
| US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
| JPS5822085B2 (en) * | 1977-07-19 | 1983-05-06 | 株式会社ミドリ十字 | Intravenous gamma globulin preparations |
| DE2837168A1 (en) * | 1978-08-25 | 1980-03-06 | Blutspendedienst Dt Rote Kreuz | METHOD FOR PRODUCING AN IMMUNAL GLOBULIN SOLUTION SUITABLE FOR INTRAVENOUS APPLICATION |
| JPS5625114A (en) * | 1979-08-07 | 1981-03-10 | Green Cross Corp:The | Preparation of human gamma globulin |
| US4374763A (en) * | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
| JPS58180433A (en) * | 1982-04-16 | 1983-10-21 | Fujirebio Inc | Method for removing anti-complement agents from immunoglobulins |
-
1982
- 1982-10-09 DE DE8282109362T patent/DE3271181D1/en not_active Expired
- 1982-10-09 EP EP82109362A patent/EP0085747B2/en not_active Expired - Lifetime
- 1982-10-09 AT AT82109362T patent/ATE19735T1/en not_active IP Right Cessation
- 1982-11-25 ZA ZA828687A patent/ZA828687B/en unknown
- 1982-12-08 AU AU91328/82A patent/AU554817B2/en not_active Expired
- 1982-12-13 PT PT75979A patent/PT75979B/en unknown
- 1982-12-14 FI FI824283A patent/FI73597C/en not_active IP Right Cessation
- 1982-12-14 JP JP57217934A patent/JPS58159424A/en active Granted
- 1982-12-14 ES ES518181A patent/ES518181A0/en active Granted
- 1982-12-21 AR AR291642A patent/AR229486A1/en active
-
1983
- 1983-01-03 PH PH28338A patent/PH20924A/en unknown
- 1983-01-24 DK DK026583A patent/DK157367C/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58159424A (en) | 1983-09-21 |
| FI824283A0 (en) | 1982-12-14 |
| DK26583A (en) | 1983-08-09 |
| DK157367C (en) | 1990-05-21 |
| AR229486A1 (en) | 1983-08-31 |
| ATE19735T1 (en) | 1986-05-15 |
| EP0085747A3 (en) | 1984-09-05 |
| PT75979A (en) | 1983-01-01 |
| FI73597C (en) | 1987-11-09 |
| JPH0365327B2 (en) | 1991-10-11 |
| FI824283L (en) | 1983-08-09 |
| ES8401983A1 (en) | 1984-01-16 |
| PT75979B (en) | 1985-10-04 |
| DK26583D0 (en) | 1983-01-24 |
| EP0085747A2 (en) | 1983-08-17 |
| AU554817B2 (en) | 1986-09-04 |
| DK157367B (en) | 1989-12-27 |
| DE3271181D1 (en) | 1986-06-19 |
| FI73597B (en) | 1987-07-31 |
| ES518181A0 (en) | 1984-01-16 |
| EP0085747B1 (en) | 1986-05-14 |
| AU9132882A (en) | 1983-08-18 |
| EP0085747B2 (en) | 1990-05-30 |
| ZA828687B (en) | 1983-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3373794D1 (en) | Process for the preparation of thermoplastic elastomers | |
| PT76830A (en) | Process for the preparation of 1h-indole-methanesulphonamides | |
| DE3166374D1 (en) | Protein hybrid having cytotoxicity and process for the preparation thereof | |
| DE3368047D1 (en) | Process for the preparation of p-nitrosodiphenylamine | |
| IL67022A (en) | 2-halo-3-chloro-5-haloalkylpyridines and process for their preparation | |
| PH20924A (en) | Intravenously administrable human immunoglobulin and process for itsa preparation | |
| CY1470A (en) | Process for the preparation of phenylalkylaminoethylsalicylamide | |
| GB2141929B (en) | Treatment of footrot | |
| DE3360650D1 (en) | Process for the preparation of o-toluidin and/or m-toluidin and/or p-toluidin | |
| ZA836193B (en) | Process for the preparation of n-allyl-o-alkyl thioncarbamates | |
| DE3372479D1 (en) | Process for the preparation of 4-chloro-2-nitrobenzonitrile | |
| DE3360101D1 (en) | Process for the manufacture of reactive-dye preparations | |
| PT76175A (en) | Process for the preparation of benzothienyl-dialkylallylamines | |
| DE3367912D1 (en) | Process for the preparation of n-allyl-o-alkyl-thioncarbamates | |
| DE3362429D1 (en) | Process for the preparation of thiadiazoloxyacetamides | |
| GB2093037B (en) | Preparation of anti-t-lymphocyte globulin | |
| DE3479806D1 (en) | Cytocidal modified immunoglobulin and process for the preparation thereof | |
| ZM8083A1 (en) | Process for the preparation of opticaly | |
| DE3364995D1 (en) | Thiophene-2-carboxylic-acid derivatives and process for their preparation | |
| DE3361356D1 (en) | Process for the preparation of 3-acylaminoanilines | |
| DE3360384D1 (en) | Process for the preparation of 1-hydroxyketones | |
| DE3369121D1 (en) | Process for the preparation of disulphides | |
| DE3360934D1 (en) | Diaryliodosyl salts and process for their preparation | |
| DE3365382D1 (en) | Process for the preparation of 2-chlorobenzoxazols | |
| DE3264841D1 (en) | 4-chloro-4-chloromethyloxetan-2-one and process for its preparation |